Psyence Biomedical (PBM) Shares Outstanding (Weighted Average) (2023 - 2025)

Psyence Biomedical's Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $68.9 billion for Q3 2025.

• In Q3 2025, Shares Outstanding (Weighted Average) rose 1692396.56% year-over-year to $68.9 billion; the TTM figure through Sep 2025 stood at $68.9 billion (up 1692396.56% YoY), while the FY2025 annual figure was $61.8 million, up 466.38% from the prior year.
• Shares Outstanding (Weighted Average) was $68.9 billion for Q3 2025 at Psyence Biomedical, up from $61.8 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $68.9 billion in Q3 2025 to a low of $4.1 million in Q3 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $26.1 billion across 3 years, with a median of $49.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 77.95% in 2024, then jumped 1692396.56% in 2025.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $49.4 million in 2023, then slumped by 91.77% to $4.1 million in 2024, then surged by 1692396.56% to $68.9 billion in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $68.9 billion (Q3 2025), $61.8 billion (Q1 2025), and $4.1 million (Q3 2024), per Business Quant data.